| Name | Smiths Pharmacy #409 |
|---|---|
| Organization Name | Smiths Food & Drug Centers Inc |
| Location | 600 E 20th St, Farmington, New Mexico 87401 |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Phone | (505) 325-1774 |
| Participate in Medicare | Medicare enrolled and may accept medicare assignment. Please check with the supplier if they accept medicare-approved amount before you get your prescription drugs, equipment or supplies from this supplier. |
News Archive
Peregrine Pharmaceuticals, Inc. (PPHM) today reported publication of data in the online edition of the journal Current Cancer Therapy Reviews that supports the clinical potential of the company's novel brain cancer agent Cotara® for the treatment of patients with glioblastoma multiforme (GBM), the deadliest form of brain cancer. Cotara specifically targets cells at the center of brain tumors, so its radioactive payload is able to kill cancer cells while leaving healthy tissue largely unaffected. Cotara is currently being tested in a Phase II clinical trial in recurrent GBM patients.
EXPERTS at the University of Huddersfield are researching the emergence of a new style of family creation that sees couples "adopt" embryos and, after the child is born, remain in contact with the donors and in many cases develop a special relationship with them.
Childhood obesity is fast becoming a major problem in the United States. However a new study shows that parents, pediatricians and even nursery schools or kindergartens have not really paid the attention the problem needs.
G-ttingen-based scientists working at DESY's PETRA III research light source have carried out the first studies of living biological cells using high-energy X-rays. The new method shows clear differences in the internal cellular structure between living and dead, chemically fixed cells that are often analysed.
New research presented at the Society for Endocrinology annual conference in Brighton appears to identify novel methods of therapy for an aggressive type of breast cancer as well as uncovering potential causative factors. The focus of the study is to show how common chemicals present in our surroundings are possibly putting women at risk of a type of breast cancer called triple negative breast cancer (TNBC).
› Verified 6 days ago
| NPI Number | 1093730616 |
| Organization Name | SMITHS FOOD & DRUG CENTERS INC |
| Doing Business As | SMITHS PHARMACY #409 |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Address | 600 E 20th St, Farmington, NM 87401 |
| Phone Number | 505-325-1774 |
News Archive
Peregrine Pharmaceuticals, Inc. (PPHM) today reported publication of data in the online edition of the journal Current Cancer Therapy Reviews that supports the clinical potential of the company's novel brain cancer agent Cotara® for the treatment of patients with glioblastoma multiforme (GBM), the deadliest form of brain cancer. Cotara specifically targets cells at the center of brain tumors, so its radioactive payload is able to kill cancer cells while leaving healthy tissue largely unaffected. Cotara is currently being tested in a Phase II clinical trial in recurrent GBM patients.
EXPERTS at the University of Huddersfield are researching the emergence of a new style of family creation that sees couples "adopt" embryos and, after the child is born, remain in contact with the donors and in many cases develop a special relationship with them.
Childhood obesity is fast becoming a major problem in the United States. However a new study shows that parents, pediatricians and even nursery schools or kindergartens have not really paid the attention the problem needs.
G-ttingen-based scientists working at DESY's PETRA III research light source have carried out the first studies of living biological cells using high-energy X-rays. The new method shows clear differences in the internal cellular structure between living and dead, chemically fixed cells that are often analysed.
New research presented at the Society for Endocrinology annual conference in Brighton appears to identify novel methods of therapy for an aggressive type of breast cancer as well as uncovering potential causative factors. The focus of the study is to show how common chemicals present in our surroundings are possibly putting women at risk of a type of breast cancer called triple negative breast cancer (TNBC).
› Verified 6 days ago
News Archive
Peregrine Pharmaceuticals, Inc. (PPHM) today reported publication of data in the online edition of the journal Current Cancer Therapy Reviews that supports the clinical potential of the company's novel brain cancer agent Cotara® for the treatment of patients with glioblastoma multiforme (GBM), the deadliest form of brain cancer. Cotara specifically targets cells at the center of brain tumors, so its radioactive payload is able to kill cancer cells while leaving healthy tissue largely unaffected. Cotara is currently being tested in a Phase II clinical trial in recurrent GBM patients.
EXPERTS at the University of Huddersfield are researching the emergence of a new style of family creation that sees couples "adopt" embryos and, after the child is born, remain in contact with the donors and in many cases develop a special relationship with them.
Childhood obesity is fast becoming a major problem in the United States. However a new study shows that parents, pediatricians and even nursery schools or kindergartens have not really paid the attention the problem needs.
G-ttingen-based scientists working at DESY's PETRA III research light source have carried out the first studies of living biological cells using high-energy X-rays. The new method shows clear differences in the internal cellular structure between living and dead, chemically fixed cells that are often analysed.
New research presented at the Society for Endocrinology annual conference in Brighton appears to identify novel methods of therapy for an aggressive type of breast cancer as well as uncovering potential causative factors. The focus of the study is to show how common chemicals present in our surroundings are possibly putting women at risk of a type of breast cancer called triple negative breast cancer (TNBC).
› Verified 6 days ago
Apria Healthcare Llc Type: Durable Medical Equipment & Medical Supplies Supplier Location: 1014 N Butler Ave, Farmington, New Mexico 87401 Phone: (505) 325-7575 | |
Classic Eyewear Inc Type: Medicare Supplier Location: 113 W Broadway, Farmington, New Mexico 87401 Phone: (505) 326-2020 | |
Cvs Pharmacy #16367 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 4900 E Main St, Farmington, New Mexico 87402 Phone: (505) 327-3555 | |
Eye Associates Of Nm Type: Medicare Supplier Location: 622 W Maple St, Farmington, New Mexico 87401 Phone: (505) 325-4003 | |
Four Corners Artificial Limb And Br Type: Durable Medical Equipment & Medical Supplies Supplier Location: 750 W Animas St, Farmington, New Mexico 87401 Phone: (505) 326-6305 |